COVID-19 Infection Linked to Higher Cytomegalovirus Response in People With HIV Receiving ART
Experts Detail the Investments Necessary to Tackle Social Determinants of Health
Texas Winter Storms Affected Health Care Access, Outcomes for Children With Epilepsy
Highlands Oncology Group’s Jeff Hunnicutt Discusses Risk Under the EOM
Review Supports Systemic Therapy's Efficacy for Severe Atopic Dermatitis
FVIII Half-life in Patients With Hemophilia Largely Determined by Clearance of VWF
AJMC® in the Press, March 10, 2023
Antibody Response to Omicron Variant Reduced 8 Months After COVID-19 Vaccination
What We’re Reading: Biden’s FY 2024 Proposed Budget; Nasal Spray for Migraine Approved; New FDA Guidelines for Mammogram Providers
Survey of Providers Indicates Need for Improved Myasthenia Gravis Management
Dr Sigrun Hallmeyer Discusses Use of Precision Medicine in the First-line Setting
Chronically Disrupted Sleep Might Increase Heart Disease Risk
Multiple Comorbid Conditions Identified as Risk Factors for Death in Severe COPD, Study Finds
Dr Kevin Davies: There Is Great Potential for CRISPR in Genetic Diseases and Cancers
Study Finds Moderate to Good Performance in Externally Validated HIV Risk Models
Multicancer Early Detection May Change the Screening Game—If We Learn From the Past
CRISPR Holds Promise in Cancer Treatment, but Challenges Remain
Faster Rates of GCIPL, cpRNFL Thinning Associated With Higher Risks of Glaucoma
Dr Andre Harvin: Pharmacists Play a Critical Role in Oncology Care
Dr Kevan Herold on Teplizumab's Future in T1D Therapy
Integrating COPD Services Results in Improved Patient Care Delivery, Study Finds
Accelerating Health Equity in Government and the Private Sector
What We’re Reading: Medicaid Health Plans Protect Members; Bayer to Expand R&D in US; Most Fatal Poisonings in Young Children Due to Opioids
Using Technology to Improve Patient Outcomes in Diabetes, Hypoglycemia
Newly Identified Metabolic Targets May Improve Treatment Strategies for CDI
Employer Playbook Suggests Strategies for Biosimilar Adoption, Navigating Adalimumab Launches
FDA Expands Approval for Companion Diagnostic for Cemiplimab in NSCLC
Lenvatinib Plus Pembrolizumab Shows Durable Efficacy Benefits vs Sunitinib in Renal Cell Carcinoma
Perampanel Demonstrates Safety, Efficacy in Treatment of Children and Adolescents With Epilepsy
Studies Presented at AAAAI Examine US Racial, Ethnic Disparities for Individuals With Asthma, Eczema